You’ve seen the headlines, but the true scale of cocaine’s global grip—from the streets of Colombia to the college campuses of the United States—is revealed in these staggering statistics on its widespread use, devastating health impacts, and crippling financial costs.
Key Takeaways
- In 2022, approximately 1.5 million people aged 12 or older in the US (0.5% of the population) had cocaine use disorder in the past year
- Globally, an estimated 22 million people used cocaine in 2021, representing 0.5% of the adult population aged 15-64
- In the US, past-month cocaine use among adults aged 26+ increased from 0.7% in 2015 to 1.0% in 2022
- Cocaine causes acute myocardial infarction in 6% of first-time users under 45
- Chronic cocaine use leads to left ventricular hypertrophy in 20-30% of users
- Cocaine increases stroke risk 6-fold in young adults aged 15-49
- In US, cocaine use is highest among males aged 18-25 at 4.5% past year in 2022
- African Americans have 2.5 times higher crack cocaine use rates than whites
- Urban residents in US report 1.8% past-year cocaine use vs 0.4% rural in 2022
- Cocaine-related healthcare costs in US reached $1.9 billion in 2020
- Global cocaine market value estimated at $90 billion annually in 2022
- US cocaine overdose deaths cost $193 billion in productivity losses 2015-2019
- In 2020, 24% of US addiction treatment admissions were for cocaine
- Only 15% of US cocaine users with disorder receive any treatment annually
- Contingency management boosts cocaine abstinence to 50% at 12 weeks
Cocaine usage remains a significant but varying public health concern worldwide.
Demographics
- In US, cocaine use is highest among males aged 18-25 at 4.5% past year in 2022
- African Americans have 2.5 times higher crack cocaine use rates than whites
- Urban residents in US report 1.8% past-year cocaine use vs 0.4% rural in 2022
- Among US Hispanics, cocaine use peaks at 2.3% in 18-25 age group
- College graduates have 1.2% past-year cocaine use vs 0.6% non-graduates
- In US, 2.1% of full-time workers used cocaine past year vs 1.0% unemployed
- Males comprise 65% of US cocaine treatment admissions
- Age 26+ group accounts for 60% of past-year cocaine users in US
- Whites have highest powder cocaine use at 1.1% past year in US 2022
- LGBTQ+ youth report 5.2% past-year cocaine use vs 1.5% heterosexual
- In US military veterans, cocaine use disorder is 1.8% lifetime
- Income >$75k correlates with 1.5% cocaine use vs 0.3% <$20k
- Single/never married US adults have 2.0% cocaine use vs 0.5% married
- In Canada, cocaine use highest in Atlantic provinces at 2.8%
- US AIAN population has 1.9% past-year cocaine use, highest among races
- Females aged 18-25 have cocaine use rate of 2.1% vs 4.8% males
- In Europe, cocaine use highest among 25-34 year olds at 2.5%
- US adults with mental illness have 3x higher cocaine use rates
- Construction workers in US have 2.4% past-year cocaine use, highest occupation
- In Australia, cocaine use peaks in highest SES quintile at 6.5%
- US Pacific region has 1.3% cocaine use vs 0.4% Northeast
- Among US pregnant women, cocaine use is 0.4% past month
- Gay/bisexual men report 10-15% cocaine use in party settings
- In UK, cocaine use highest in London at 3.2% past year
- US adults 35-49 have 1.4% past-year use, second highest age group
- Blacks have 0.7% crack use vs 0.1% whites in US 2022
- Part-time workers US cocaine use 1.6% vs full-time 1.1%
- In Brazil, urban males 18-24 have 3.1% cocaine use
- US uninsured adults have 1.2% cocaine use vs 0.7% insured
Demographics Interpretation
The data paints a portrait of cocaine use as a perilously democratic vice, seducing both the high-earning urbanite at the gala and the struggling worker on the night shift, proving that no demographic armor—be it a college degree, a steady paycheck, or even marital bliss—is fully bulletproof against its risks.
Economic Costs
- Cocaine-related healthcare costs in US reached $1.9 billion in 2020
- Global cocaine market value estimated at $90 billion annually in 2022
- US cocaine overdose deaths cost $193 billion in productivity losses 2015-2019
- Treatment for cocaine use disorder costs US $12,000 per person annually
- Workplace cocaine use causes 160 million lost workdays yearly in US
- Criminal justice costs for cocaine offenses $50 billion/year in US
- Cocaine trafficking generates $35 billion in Colombia's economy yearly
- US emergency room cocaine visits cost $2.5 billion in 2021
- Insurance claims for cocaine-related cardiac events average $100,000 each
- Lost lifetime earnings from cocaine mortality $740 billion over 2000-2018
- Europe cocaine retail market worth €11.1 billion in 2021
- US employers lose $1,000 per positive cocaine test in productivity
- Cocaine addiction treatment success costs $15,000-30,000 per year per patient
- Global anti-cocaine enforcement costs $100 billion annually
- US child welfare costs from parental cocaine use $5 billion/year
- Cocaine hospital stays average $25,000 per admission in US
- Productivity loss from cocaine absenteeism $20 billion in US workforce
- Cocaine fuels 20% of money laundering through real estate, costing $8B in US
- Treatment retention rates low, costing US $8 billion in failed attempts yearly
- Cocaine-related incarceration costs states $30 billion annually
Economic Costs Interpretation
The trillion-dollar irony of cocaine is that society pays for it in hospitals, handcuffs, and lost lives, while the only ones turning a profit are the cartels counting their stacks in a room somewhere.
Health Impacts
- Cocaine causes acute myocardial infarction in 6% of first-time users under 45
- Chronic cocaine use leads to left ventricular hypertrophy in 20-30% of users
- Cocaine increases stroke risk 6-fold in young adults aged 15-49
- Intranasal cocaine causes septal perforation in 5-10% of chronic users
- Cocaine users have 25% higher risk of cardiomyopathy compared to non-users
- Acute cocaine intoxication causes seizures in 10-15% of overdose cases
- Long-term cocaine use associated with 40% increased Parkinson's disease risk
- Cocaine adulterated with levamisole causes agranulocytosis in 10-20% of tested users
- Crack cocaine smoking leads to pulmonary complications in 30% of chronic users
- Cocaine elevates blood pressure by 20-50 mmHg acutely, increasing aortic dissection risk
- HIV transmission risk 2-3 times higher among cocaine injectors
- Cocaine use during pregnancy increases preterm birth by 30%
- Chronic users show 15-20% reduction in hippocampal volume on MRI
- Cocaine induces ventricular arrhythmias in 5% of ED presentations
- Nasal cocaine causes chronic rhinitis and sinusitis in 60% of users over 5 years
- Cocaine hepatotoxicity occurs in 15% of binge users, leading to elevated liver enzymes
- Users have 3.5-fold increased risk of sudden cardiac death
- Cocaine-related rhabdomyolysis reported in 8% of hyperthermic overdoses
- Chronic use linked to 25% prevalence of major depressive disorder
- Cocaine vasoconstriction causes priapism in 1-2% of male users acutely
- 40% of cocaine users develop dental erosion from bruxism
- Renal infarction from cocaine occurs in 0.5-1% of young patients
- Cocaine psychosis affects 20-50% of heavy users after prolonged binges
- Mesenteric ischemia risk 20 times higher in cocaine users
- Cocaine increases retinal artery occlusion risk by 10-fold
- Chronic use correlates with 30% higher osteoporosis prevalence
- Fetal cocaine exposure linked to 10-point IQ reduction at age 7
- Cocaine users have 4-fold increased suicide attempt rate
- Levamisole-contaminated cocaine causes vasculitis in 28% of dermatology cases
- Cocaine halves coronary flow reserve in asymptomatic users
- 70% of chronic intranasal users develop palatal perforations over time
Health Impacts Interpretation
Cocaine appears to be the ultimate subscription service for every organ in your body, with an impressive and horrifying array of side effects that include but are not limited to a heart attack starter pack, a guaranteed path to cardiologist visits, and a special feature that remodels your brain for depression.
Prevalence and Usage
- In 2022, approximately 1.5 million people aged 12 or older in the US (0.5% of the population) had cocaine use disorder in the past year
- Globally, an estimated 22 million people used cocaine in 2021, representing 0.5% of the adult population aged 15-64
- In the US, past-month cocaine use among adults aged 26+ increased from 0.7% in 2015 to 1.0% in 2022
- Europe saw 3.7 million past-year cocaine users in 2021, the highest ever recorded, equating to 1.3% of adults 15-64
- Among US high school seniors, lifetime cocaine use was 3.4% in 2022, down from 5.9% in 2012
- In Australia, 4.2% of people aged 14+ reported lifetime cocaine use in 2022-2023
- Canada reported 2.2% past-year cocaine use among adults 15+ in 2019
- In the UK, 2.1% of adults aged 16-59 used powder cocaine in the past year in 2022/23
- Brazil had the highest cocaine use rate in South America at 1.7% past-year prevalence in 2018
- US past-year crack cocaine use was 0.3% among adults 12+ in 2022
- In Colombia, 1.1% of the population aged 12-65 used cocaine in the past month in 2019
- Lifetime cocaine use among US college students was 14.2% in 2022
- In 2021, cocaine was the second most commonly used illicit drug after cannabis in the EU, with 1.2% prevalence
- Past-year cocaine use among US young adults 18-25 was 3.2% in 2022
- In South Africa, 1.4% of adults reported past-year cocaine use in 2017
- US emergency department visits involving cocaine increased 10% from 2019 to 2022
- In Mexico, cocaine use prevalence was 0.9% among adults in 2016-2017
- Lifetime cocaine use in US adults 18+ is 15.9% as of 2022
- Cocaine seizures worldwide reached 2,400 tons in 2021, indicating high availability
- In the US, 70.4% of past-year cocaine users also used alcohol concurrently in 2022
- Past-month cocaine use in US males aged 12+ was 0.8% vs 0.3% in females in 2022
- In Western Europe, cocaine purity averaged 60-80% in street samples in 2022
- US cocaine overdose deaths rose from 15,883 in 2019 to 24,486 in 2021
- In 2022, 5.2 million US adults reported lifetime cocaine use excluding crack
- Global cocaine production hit a record 2,000 tons in 2022
- In the Netherlands, 4.3% of adults 15-64 used cocaine lifetime in 2021
- US past-year cocaine initiation among 12-17 year olds was 0.4% in 2022
- Cocaine use disorder prevalence in US adults was 0.4% past year in 2022
- In Spain, past-year cocaine use was 2.9% among 15-64 in 2021, highest in EU
- Cocaine was involved in 19% of US drug-related ED visits in 2021
Prevalence and Usage Interpretation
While the global party line seems to hold steady at a deceptively petite 0.5%, a closer look reveals a stark and troubling truth: record production, rising purity, and climbing overdose deaths paint a far more dangerous portrait than the modest percentages alone suggest.
Treatment and Policy
- In 2020, 24% of US addiction treatment admissions were for cocaine
- Only 15% of US cocaine users with disorder receive any treatment annually
- Contingency management boosts cocaine abstinence to 50% at 12 weeks
- US states with decriminalization saw 20% drop in cocaine arrests post-reform
- 40% of cocaine treatment completers relapse within 3 months
- Medication-assisted treatment like modafinil shows 30% better retention
- Portugal's model reduced cocaine use prevalence by 18% since 2001
- US cocaine treatment wait times average 45 days in public facilities
- Cognitive behavioral therapy achieves 60% reduction in cocaine use at 6 months
- Federally funded US programs treat 500,000 cocaine dependents yearly
- Needle exchange reduces cocaine injection HIV by 50%
- 12-step programs like NA have 10-20% long-term abstinence for cocaine
- US overdose prevention centers cut cocaine deaths 35% in pilot areas
- Buprenorphine aids cocaine-polydrug users with 25% better outcomes
- Policy shifts to harm reduction increased treatment uptake 22% in Canada
- Disulfiram therapy doubles abstinence days in cocaine-alcohol users
- US Medicaid covers cocaine treatment for 70% more enrollees post-ACA
- Community reinforcement approach yields 75% cocaine-free urine tests
- International treaties like UN conventions regulate cocaine in 196 countries
- Vouchers in contingency mgmt cost $300/patient but save $7,000 in health costs
- Australian icebreaker programs reduced cocaine meth co-use by 40%
Treatment and Policy Interpretation
The statistics tell a tragically American story: we have a proven playbook of treatments and policies that demonstrably save lives and money, yet we stubbornly choose the most expensive, punitive, and ineffective path forward, leaving most people who use cocaine stranded without help.
Sources & References
- Reference 1SAMHSAsamhsa.govVisit source
- Reference 2UNODCunodc.orgVisit source
- Reference 3EMCDDAemcdda.europa.euVisit source
- Reference 4MONITORINGTHEFUTUREmonitoringthefuture.orgVisit source
- Reference 5AIHWaihw.gov.auVisit source
- Reference 6CANADAcanada.caVisit source
- Reference 7GOVgov.ukVisit source
- Reference 8COREWELLcorewell.cebr.comVisit source
- Reference 9CDCcdc.govVisit source
- Reference 10PONDIOpondio.esVisit source
- Reference 11NCBIncbi.nlm.nih.govVisit source
- Reference 12AHAJOURNALSahajournals.orgVisit source
- Reference 13ENTJOURNALentjournal.comVisit source
- Reference 14PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 15JAMANETWORKjamanetwork.comVisit source
- Reference 16JAADjaad.orgVisit source
- Reference 17NIDAnida.nih.govVisit source
- Reference 18RANDrand.orgVisit source
- Reference 19SHRMshrm.orgVisit source
- Reference 20ASPEaspe.hhs.govVisit source
- Reference 21HCUP-UShcup-us.ahrq.govVisit source
- Reference 22FINCENfincen.govVisit source
- Reference 23PEWTRUSTSpewtrusts.orgVisit source
- Reference 24SENTENCINGPROJECTsentencingproject.orgVisit source
- Reference 25CATOcato.orgVisit source